Pancreatic stent does not provided added advantage over rectal NSAID for prevention of post-ERCP pancreatitis: First ever RCT
DOI: 10.1097/MPA.0000000000002090
Consecutive 321 patients with native papilla, were randomly assigned to Pancreatic stent, 50mg rectal diclofenac or stent + diclofenac at a single centre in Japan from 2014 to 2019.
Pancreaitc injection performed in nearly half of all patients!
75% of all patients were considered high risk (either F<40, difficult cannulation, pancreatic cannulation, pancreatic injection, pre-cut, pancreatic sphincteortomy, balloon sphincteroplasty, IDUS, choledochoscopy)
Procedure time was >30 mins in half of all patients.
5 patients in total developed pancreatitis (all mild), with no difference in any of the 3 sub-groups.
Comments
Post a Comment